News – Page 372 – Endpoints News

Following the government's lead, Lilly caps out-of-pocket costs for insulin at $35 per month

3 years ago

A radioactive prostate cancer therapy is a last lifeline for patients. Novartis can't make enough of it

3 years ago

Keytruda hits one primary endpoint for use before and after surgery in lung cancer

3 years ago

Amicus eyes Pompe approval; Atea ends Dengue work; 2seventy, Travere line up offerings

3 years ago

Ex-AveXis crew trims staff at Chicago-area Jaguar Gene Therapy

3 years ago

Alex Denner secures victory in Amarin vote, ousting chair and adding supporters to board

3 years ago

Cell therapy biotech from Stanford CAR-T leader Crystal Mackall nabs $200M for PhII

3 years ago

TandemAI raises $35M in Series A for small molecule discovery, wet labs

3 years ago

G1 Therapeutics delays PhIII readout of lead drug — will cut 30% of staff, CFO to exit

3 years ago

Ready to turn a new page, Landos Biopharma offloads former lead program to founder

3 years ago

Sarepta won't need FDA adcomm, boosting Duchenne gene therapy's odds

3 years ago

A gene editing 3.0 player goes deep on cash, frontier science to put precision epigenetics to the big test

3 years ago

Regenerative cell biotech Thymmune launches with backing from George Church, John Maraganore

3 years ago

FDA rejects Cytokinetics' heart failure drug, but the biotech has a backup

3 years ago

Struggling Novavax details a wave of red ink and plots survival course after raising 'going concern' alert

3 years ago

FDA finally approves Reata's rare genetic disease drug

3 years ago

Novavax raises warning about ability to stay in business

3 years ago

Pfizer's RSV vaccine for older adults nabs FDA adcomm recommendation

3 years ago

Pharmas' reputations matter, especially when it comes to writing prescriptions, new survey finds

3 years ago

FDA set to open comments on AI use in pharma manufacturing

3 years ago

Pfizer was warned of Lyme study problems months ago, trial research startup's CEO tells employees

3 years ago

Rare Disease Day pulls more participation, creativity and diversity in 2023 pharma and advocacy campaigns

3 years ago

MarketingRx roundup: AbbVie joins TikTok with friendly expert chats; Pfizer shops $2.8B marketing account

3 years ago

In push to expand its CAR-T therapies to US, China biotech Oricell raises additional $45M

3 years ago

First page Previous page 369 370 371372373 374 375 Next page Last page